Is EWTX or LIVN more profitable?

LIVN runs the higher net margin — EWTX at 0.00% versus LIVN at 12.82%.

How have EWTX and LIVN total returns compared?

Over the past 5 years, EWTX delivered 16.95% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

Edgewise Therapeutics, Inc. (EWTX) vs LivaNova PLC (LIVN)

A side-by-side comparison of Edgewise Therapeutics, Inc. and LivaNova PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EWTX

Edgewise Therapeutics, Inc.

$4.30B

$39.94HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

LIVN

LivaNova PLC

$4.13B

$75.11HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — EWTX vs LIVN

growth of $100 · dividends reinvested · last 6y

EWTX +34.3% (+5.0%/yr)LIVN +0.6% (+0.1%/yr)EWTX compounded faster over this window

EWTX LIVN

EWTX vs LIVN: by the numbers

•EWTX is the larger company ($4.30B vs $4.13B market cap).
•LIVN is profitable (12.82% net margin) while EWTX runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	EWTX	LIVN
P/E ratio	N/A	22.16
Forward P/E	N/A	17.24
P/S ratio	N/A	2.80
P/B ratio	9.59	3.11
EV / EBITDA	N/A	16.21
FCF yield	N/A	3.60%

Profitability

Metric	EWTX	LIVN
Gross margin	0.00%	68.18%
Operating margin	0.00%	13.48%
Net margin	0.00%	12.82%
ROE	-44.02%	14.23%
ROIC	-48.57%	10.24%

Growth (annualized)

Metric	EWTX	LIVN
Revenue CAGR (5Y)	N/A	7.57%
FCF CAGR (5Y)	N/A	20.23%
Total return CAGR (5Y)	16.95%	-1.66%

Frequently asked

Is EWTX or LIVN more profitable?: LIVN runs the higher net margin — EWTX at 0.00% versus LIVN at 12.82%.
How have EWTX and LIVN total returns compared?: Over the past 5 years, EWTX delivered 16.95% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EWTX analysis Full LIVN analysis Interactive comparison tool

Dig into the metrics

LivaNova P/E ratio Edgewise Therapeutics ROE LivaNova ROE Edgewise Therapeutics operating margin LivaNova operating margin Edgewise Therapeutics revenue growth LivaNova revenue growth Edgewise Therapeutics free cash flow LivaNova free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.